ARK Genomic Revolution ETF vs Exxon Mobil Corporation — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Exxon Mobil Corporation trades at $140.78 (market cap $575.65B). The key difference: Exxon Mobil Corporation pays a 2.97% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Exxon Mobil Corporation nearer its low. Which is the better fit depends on your goals.
| ARKG | XOM | |
|---|---|---|
Sector | Sector/Thematic | Energy |
52-Week High | $43.57 | $171.52 |
52-Week Low | $23.09 | $105.83 |
Market Cap | — | $575.65B |
Enterprise Value | — | $614.88B |
Dividend Yield | — | 2.97% |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
ExxonMobil (XOM) trades at $138.83, up 1.06% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported Q1 2026 EPS of $1.16, beating estimates, while revenue declined to $323.91 billion in 2025. Analyst consensus is mixed with 42.59% buy ratings and a $169.30 price target. Recent news highlights Exxon's Permian Basin advantages and warnings of potential oil price spikes to $160 per barrel amid Middle East tensions.
XOM offers value with a P/E of 23.38 and strong cash flow, but faces headwinds from declining revenue and net income margins. Investment appeal hinges on oil price stability and execution in low-breakeven assets like the Permian Basin. Risks include volatile energy markets and geopolitical tensions affecting global supply.
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Exxon Mobil Corporation operates petroleum and petro chemicals businesses. The Company provides operations include exploration and production of oil and gas, electric power generation, and coal and minerals operations. Exxon Mobil also manufactures and markets fuels, lubricants, and chemicals. Exxon Mobil serves customers worldwide.
Read more on XOM →